Gene therapy for autoimmune diseases: quo vadis?
- 1 October 2004
- journal article
- review article
- Published by Springer Nature in Nature Reviews Immunology
- Vol. 4 (10) , 800-811
- https://doi.org/10.1038/nri1459
Abstract
No abstract availableKeywords
This publication has 100 references indexed in Scilit:
- Creation of immune ‘stealth’ genes for gene therapy through fusion with the Gly-Ala repeat of EBNA-1Gene Therapy, 2003
- Localized expression of an anti-TNF single-chain antibody prevents development of collagen-induced arthritisGene Therapy, 2003
- Occurrence of leukaemia following gene therapy of X-linked SCIDNature Reviews Cancer, 2003
- Injection of adult neurospheres induces recovery in a chronic model of multiple sclerosisNature, 2003
- Ex vivo and systemic transfer of adenovirus-mediated CTLA4Ig gene combined with a short course of FK506 therapy prolongs islet graft survivalTransplant Immunology, 2003
- Gene therapy of streptozotocin‐induced diabetes by intramuscular delivery of modified preproinsulin genesThe Journal of Gene Medicine, 2002
- Targeting autoantigen-specific T cells and suppression of autoimmune encephalomyelitis with receptor-modified T lymphocytesNature Biotechnology, 2002
- C3‐Tat/HIV–regulated intraarticular human interleukin‐1 receptor antagonist gene therapy results in efficient inhibition of collagen‐induced arthritis superior to cytomegalovirus‐regulated expression of the same transgeneArthritis & Rheumatism, 2002
- Articular cartilage repair: basic science and clinical progress. A review of the current status and prospectsOsteoarthritis and Cartilage, 2002
- Interleukin-13 Gene Therapy Reduces Inflammation, Vascularization, and Bony Destruction in Rat Adjuvant-Induced ArthritisHuman Gene Therapy, 2002